Skip to content
Back to catalogue
CJC-1295 (No DAC) pen, black
CJC-1295 (No DAC) pen, pink

Growth hormone release

CJC-1295 (No DAC)

The classic partner to Ipamorelin

Format

Add a refill for your pen

CJC-1295 (No DAC) 10 mg · +AED 735 each

0

Quantity — buy more, save more

Other quantity

1

Any mix counts: items from other products add up too.

PriceAED 780

Frequently paired with

Tap Add — each one counts toward your bundle saving.

Ipamorelin 10 mg

AED 730

Also in a bundle: GH research duo

Add another item from the catalogue

Pens are added as the reusable pen; change the format on the product page if you prefer.

A growth-hormone releasing hormone analogue that clears quickly, producing one sharp pulse. Commonly studied alongside Ipamorelin, where the two give a stronger release than either alone.

Research use only. Supplied for laboratory and analytical research. Not a medicine or supplement, and not for human or animal use. We don't give dosing or clinical advice. Read the terms

Presentation
Lyophilised powder, reconstituted — 3 mL pen

Manufactured under controlled research-grade conditions. For documentation or questions about this compound, contact us on WhatsApp.

Published research

  1. Human trial

    Using CJC-1295 with DAC (no published study used the no-DAC form): in two randomised placebo-controlled trials in healthy adults, it produced sustained, dose-dependent increases in GH and IGF-I.

    Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. The Journal of Clinical Endocrinology and Metabolism. 2006. PMID 16352683

  2. Human trial

    Using CJC-1295 with DAC: in healthy young men, a single injection raised baseline and average GH and IGF-I levels while the natural pulse pattern of GH was preserved.

    Ionescu M, et al. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. The Journal of Clinical Endocrinology and Metabolism. 2006. PMID 17018654

  3. Animal study

    Using CJC-1295 with DAC: in rats and cultured rat pituitary cells, this albumin-binding modified GRF(1-29) stimulated GH release and stayed in the blood for more than 72 hours.

    Jetté L, et al. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. 2005. PMID 15817669

  4. Animal study

    Using CJC-1295 with DAC: in mice lacking natural GHRH, repeated treatment maintained normal body weight, length and body composition and increased pituitary GH production.

    Alba M, et al. Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. American Journal of Physiology. Endocrinology and Metabolism. 2006. PMID 16822960

Short summaries of published studies, with links to the original papers. Results in animals or cells may not apply to people. This is not medical advice and not a guide to use.

All research on CJC-1295 (No DAC)